Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
CROs
>
i3 Research
>
New Policies
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 4268815"]It sounds like the pharmanet senior management has completely taken over. Nothing's left of inventiv even though inventiv bought the company, they gave pharmanet and jeff mcmullen all of the power. he seems to hate his employees. both the inventiv workers and the i3 workers were much happier before pharmanet came along and took away all of their benefits. the turnover is going to be astounding. A lot of people haven't left yet because they work from home, but the company will lose everyone over this.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 4268815"]It sounds like the pharmanet senior management has completely taken over. Nothing's left of inventiv even though inventiv bought the company, they gave pharmanet and jeff mcmullen all of the power. he seems to hate his employees. both the inventiv workers and the i3 workers were much happier before pharmanet came along and took away all of their benefits. the turnover is going to be astounding. A lot of people haven't left yet because they work from home, but the company will lose everyone over this.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
CROs
>
i3 Research
>
New Policies
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
CROs
>
i3 Research
>
New Policies
>